Capital Research & Management Co recently announced the acquisition of new stake in Grifols SA ADR (NASDAQ:GRFS). The institutional investor has increased its shareholding in the Healthcare company by 0.58% to 19.63 million shares with purchase of 0.11 million shares. This fresh investment now brings its stake to 7.51% valued currently at $190.21 million. In addition, Brandes Investment Partners LP raised its holdings by 0.84 million to 11.06 million shares. And Black Creek Investment Management has lifted its position by 16.43% or 1.35 million shares – to 9.57 million shares.
With over 23.72 million Grifols SA ADR (GRFS) shares trading Tuesday and a closing price of $8.70 on the day, the dollar volume was approximately $206.33 million. The shares have shown a negative half year performance of -7.15% and its price on 01/09/24 lost nearly -21.83%. Currently, there are 256.48M common shares owned by the public and among those 256.33M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 5 analysts who have offered their price forecasts for GRFS have a consensus price objective of $19.32. The analysts have set the share’s price value over the next 12 months at a high of $27.80 and a low of $12.00. The average price target is 52.97% above its recent price level and an upside to the estimated low will see the stock gain 27.5% over that period. But an upside of 68.71% will see the stock hit the forecast high price target while median target price for the stock is $18.75.
The top 3 mutual fund holders in Grifols SA ADR are American Funds New Perspective Fu, First Trust NYSE Arca Biotechnolo, and American Funds International Grow. American Funds New Perspective Fu owns 13.38 million shares of the company’s stock, all valued at over $129.66 million. American Funds International Grow sold 3285.0 shares to bring its total holdings to over 4.0 million shares at a value of $38.75 million. American Funds International Grow now owns shares totaling to 1.53% of the shares outstanding.
Shares of Grifols SA ADR (NASDAQ: GRFS) opened at $7.42, down -$3.71 from a prior closing price of $11.13. However, the script later moved the day high at 8.80, down -21.83%. The company’s stock has a 5-day price change of -21.27% and 2.11% over the past three months. GRFS shares are trading -24.74% year to date (YTD), with the 12-month market performance down to -2.79% lower. It has a 12-month low price of $6.50 and touched a high of $12.15 over the same period. GRFS has an average intraday trading volume of 903.67K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -18.19%, -11.14%, and -4.38% respectively.
Institutional ownership of Grifols SA ADR (NASDAQ: GRFS) shares accounts for 47.51% of the company’s 256.48M shares outstanding. Mutual fund holders own 19.74%, while other institutional holders and individual stakeholders account for 27.02% and — respectively.
It has a market capitalization of $2.23B and a beta (3y monthly) value of 0.60. The stock’s trailing 12-month PE ratio is 1242.86, while the earnings-per-share (ttm) stands at $0.01. The company has a PEG of 38.36 and a Quick Ratio of 0.79 with the debt-to-equity ratio at 1.71. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.63% over the week and 4.06% over the month.
Analysts forecast that Grifols SA ADR (GRFS) will achieve an EPS of $0.24 for the current quarter, $0 for the next quarter and $1.05 for 2024. The lowest estimate earnings-per-share for the quarter is $0.24 while analysts give the company a high EPS estimate of $0.24. Comparatively, EPS for the current quarter was $0.28 a year ago. Earnings per share for the fiscal year are expected to increase by 6.71%, and 110.16% over the next financial year. EPS should grow at an annualized rate of 32.40% over the next five years, compared to -21.67% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 5 brokerage firm advisors rate Grifols SA ADR (GRFS) as a “Strong Buy” at a consensus score of 1.80. Specifically, 2 Wall Street analysts polled rate the stock as a buy, while 1 of the 5 advise that investors “hold,” and 0 rated it as a “Sell.”
